Edition:
United States

Aevi Genomic Medicine Inc (GNMX.OQ)

GNMX.OQ on NASDAQ Stock Exchange Global Market

1.62USD
23 Mar 2017
Change (% chg)

$-0.08 (-4.71%)
Prev Close
$1.70
Open
$1.73
Day's High
$1.73
Day's Low
$1.57
Volume
302,003
Avg. Vol
112,473
52-wk High
$6.89
52-wk Low
$1.50

GNMX.OQ

Chart for GNMX.OQ

About

Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate genetic discoveries into therapies. The Company is engaged in developing therapies for children and adults with pediatric onset life altering diseases. The... (more)

Overall

Beta: 0.89
Market Cap(Mil.): $63.09
Shares Outstanding(Mil.): 37.11
Dividend: --
Yield (%): --

Financials

  GNMX.OQ Industry Sector
P/E (TTM): -- 48.09 29.63
EPS (TTM): -1.20 -- --
ROI: -98.22 -2.54 13.01
ROE: -98.22 5.17 14.16

BRIEF-Aevi Genomic Medicine provides top-line results from saga trial

* Aevi Genomic Medicine provides top-line results from the saga trial of aevi-001

Mar 20 2017

BRIEF-Aevi Genomic Medicine reports Q4 loss per share $0.23

* Aevi Genomic Medicine reports fourth quarter and full year 2016 financial results and provides business update

Mar 09 2017

More From Around the Web

Earnings vs. Estimates